About Us
Prohibition Partners unlocks the potential of cannabis through data, intelligence and strategy. We provide strategic solutions to an international client base of investors, operators, blue chip companies, FMCG brands and government bodies.
We deliver unique insights to our clients, whilst driving sustainable business growth and progressive change to the benefit of industry, investors, regulators as well as patients and consumers.
Press releases
UK’s Medical Cannabis Boom: Patients, Demand and Consumption Surge to...
The UK is the primary driver of new growth in Europe’s medical cannabis market, with sales of medical cannabis greater than expected due to... read more
09.05.2024 • By Prohibition Partners
1.6 MILLION MEDICAL CANNABIS PATIENTS IN EUROPE BY 2026 - OVER 340,000...
[London, United Kingdom, Wednesday 6 April] 100,000 patients will be able to access medical cannabis products in Europe for the first time in... read more
06.04.2022 • By Prohibition Partners
Getting psyched for healthcare: Global event to connect businesses and...
First edition of PSYCH Investor Summit: Europe & Asia to connect psychedelics healthcare businesses with leading European and APAC investors... read more
16.04.2021 • By Prohibition Partners
Legal Cannabis Market in Europe Set to be Worth €3.2 billion by 2025
The European cannabis market is forecast to grow with a compound annual growth rate (CAGR) of 67.4% to reach €3.2 billion by 2025, a new report... read more
30.03.2021 • By Prohibition Partners
